Wargacki Stephen
Insider CIK 1960165 · AQST SVP, Research & Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics, In | F Tax w/h | 2025-03-10 | 2025-03-11 | 4,572 | $2.54 | $11.6K | 343,552 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2025-03-09 | 2025-03-11 | 15,431 | $2.65 | $40.9K | 348,124 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2025-03-07 | 2025-03-11 | 65,000 | — | $0 | 65,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2025-03-07 | 2025-03-11 | 12,859 | $2.65 | $34.1K | 363,555 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2025-03-07 | 2025-03-11 | 115,000 | — | $0 | 376,414 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2024-05-10 | 2024-05-13 | 10,000 | — | $0 | 267,963 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2024-03-10 | 2024-03-12 | 1,687 | $4.88 | $8.2K | 257,963 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2024-03-09 | 2024-10-02 | 19,505 | $4.88 | $95.2K | 261,414 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2024-03-09 | 2024-03-12 | 11,269 | $4.88 | $55.0K | 259,650 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2024-03-07 | 2024-03-11 | 56,250 | — | $0 | 56,250 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2024-03-07 | 2024-03-11 | 112,500 | — | $0 | 270,919 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2023-08-09 | 2023-08-09 | 67,500 | — | $0 | 67,500 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2023-05-05 | 2023-05-05 | 67,500 | — | $0 | 67,500 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2023-03-10 | 2024-03-11 | 1,981 | $0.79 | $1.6K | 158,419 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2023-03-09 | 2023-03-09 | 135,000 | — | $0 | 161,956 | SEC↗ |